GB202102224D0 - Anti-TRC delta variable 1 antibodies - Google Patents

Anti-TRC delta variable 1 antibodies

Info

Publication number
GB202102224D0
GB202102224D0 GBGB2102224.9A GB202102224A GB202102224D0 GB 202102224 D0 GB202102224 D0 GB 202102224D0 GB 202102224 A GB202102224 A GB 202102224A GB 202102224 D0 GB202102224 D0 GB 202102224D0
Authority
GB
United Kingdom
Prior art keywords
trc
antibodies
delta variable
delta
variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2102224.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaptate Biotherapeutics Ltd
Original Assignee
Adaptate Biotherapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaptate Biotherapeutics Ltd filed Critical Adaptate Biotherapeutics Ltd
Priority to GBGB2102224.9A priority Critical patent/GB202102224D0/en
Publication of GB202102224D0 publication Critical patent/GB202102224D0/en
Priority to BR112023002741A priority patent/BR112023002741A2/en
Priority to CN202180069269.3A priority patent/CN116209456A/en
Priority to EP23187272.2A priority patent/EP4269445A3/en
Priority to PL21756070.5T priority patent/PL4010082T3/en
Priority to SI202130032T priority patent/SI4010082T1/en
Priority to EP23187269.8A priority patent/EP4269444A3/en
Priority to PCT/IB2021/057509 priority patent/WO2022034562A1/en
Priority to IL300517A priority patent/IL300517A/en
Priority to FIEP21756070.5T priority patent/FI4010082T3/en
Priority to MX2023001728A priority patent/MX2023001728A/en
Priority to ES21756070T priority patent/ES2943063T3/en
Priority to EP21756070.5A priority patent/EP4010082B1/en
Priority to AU2021323512A priority patent/AU2021323512A1/en
Priority to PT217560705T priority patent/PT4010082T/en
Priority to JP2023510439A priority patent/JP2023537534A/en
Priority to CA3188682A priority patent/CA3188682A1/en
Priority to EP23187270.6A priority patent/EP4265642A3/en
Priority to LTEPPCT/IB2021/057509T priority patent/LT4010082T/en
Priority to DK21756070.5T priority patent/DK4010082T3/en
Priority to EP23153152.6A priority patent/EP4218932A3/en
Priority to EP23187273.0A priority patent/EP4269446A3/en
Priority to EP23187271.4A priority patent/EP4265643A3/en
Priority to KR1020237005145A priority patent/KR20230083267A/en
Priority to IL305266A priority patent/IL305266A/en
Priority to PCT/EP2022/054004 priority patent/WO2022175413A1/en
Priority to PE2023002380A priority patent/PE20240591A1/en
Priority to US17/674,129 priority patent/US20230028110A1/en
Priority to BR112023016580A priority patent/BR112023016580A2/en
Priority to KR1020237031273A priority patent/KR20230160254A/en
Priority to EP22706805.3A priority patent/EP4294529A1/en
Priority to ARP220100334A priority patent/AR124909A1/en
Priority to ARP220100335A priority patent/AR124910A1/en
Priority to MX2023009360A priority patent/MX2023009360A/en
Priority to EP22705063.0A priority patent/EP4294527A1/en
Priority to IL305024A priority patent/IL305024A/en
Priority to JP2023573494A priority patent/JP2024509332A/en
Priority to CA3207265A priority patent/CA3207265A1/en
Priority to AU2022224391A priority patent/AU2022224391A1/en
Priority to JP2023548885A priority patent/JP2024506682A/en
Priority to BR112023016587A priority patent/BR112023016587A2/en
Priority to PCT/EP2022/054011 priority patent/WO2022175414A1/en
Priority to KR1020237031271A priority patent/KR20230160253A/en
Priority to TW111105807A priority patent/TW202246338A/en
Priority to AU2022222299A priority patent/AU2022222299A1/en
Priority to TW111105808A priority patent/TW202302639A/en
Priority to CONC2023/0003009A priority patent/CO2023003009A2/en
Priority to US18/451,047 priority patent/US20240132599A1/en
Priority to CL2023002435A priority patent/CL2023002435A1/en
Priority to CONC2023/0011853A priority patent/CO2023011853A2/en
Priority to CONC2023/0011973A priority patent/CO2023011973A2/en
Priority to ECSENADI202370428A priority patent/ECSP23070428A/en
Ceased legal-status Critical Current

Links

GBGB2102224.9A 2020-08-14 2021-02-17 Anti-TRC delta variable 1 antibodies Ceased GB202102224D0 (en)

Priority Applications (52)

Application Number Priority Date Filing Date Title
GBGB2102224.9A GB202102224D0 (en) 2021-02-17 2021-02-17 Anti-TRC delta variable 1 antibodies
BR112023002741A BR112023002741A2 (en) 2020-08-14 2021-08-14 MULTI-SPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES
CN202180069269.3A CN116209456A (en) 2020-08-14 2021-08-14 Multispecific anti-TCR delta variable 1 antibodies
EP23187272.2A EP4269445A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
PL21756070.5T PL4010082T3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
SI202130032T SI4010082T1 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
EP23187269.8A EP4269444A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
PCT/IB2021/057509 WO2022034562A1 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
IL300517A IL300517A (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
FIEP21756070.5T FI4010082T3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
MX2023001728A MX2023001728A (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies.
ES21756070T ES2943063T3 (en) 2020-08-14 2021-08-14 Variable delta TCR 1 multispecific antibodies
EP21756070.5A EP4010082B1 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
AU2021323512A AU2021323512A1 (en) 2020-08-14 2021-08-14 Multispecific anti-TCR delta variable 1 antibodies
PT217560705T PT4010082T (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
JP2023510439A JP2023537534A (en) 2020-08-14 2021-08-14 Multispecific anti-TCR delta variable 1 antibody
CA3188682A CA3188682A1 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
EP23187270.6A EP4265642A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
LTEPPCT/IB2021/057509T LT4010082T (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
DK21756070.5T DK4010082T3 (en) 2020-08-14 2021-08-14 MULTISPECIFIC ANTIBODIES AGAINST VARIABLE ANTI-TCR-DELTA 1
EP23153152.6A EP4218932A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
EP23187273.0A EP4269446A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
EP23187271.4A EP4265643A3 (en) 2020-08-14 2021-08-14 Multispecific anti-tcr delta variable 1 antibodies
KR1020237005145A KR20230083267A (en) 2020-08-14 2021-08-14 Multispecific Anti-TCR Delta Variable 1 Antibody
IL305266A IL305266A (en) 2021-02-17 2022-02-17 Multispecific anti-tcr delta variable 1 antibodies
PCT/EP2022/054004 WO2022175413A1 (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
PE2023002380A PE20240591A1 (en) 2021-02-17 2022-02-17 MULTI-SPECIFIC TCR ANTI-VARIABLE DELTA 1 ANTIBODIES
US17/674,129 US20230028110A1 (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
BR112023016580A BR112023016580A2 (en) 2021-02-17 2022-02-17 ANTI-TCR DELTA VARIABLE 1 ANTIBODIES
KR1020237031273A KR20230160254A (en) 2021-02-17 2022-02-17 Multispecific anti-TCR delta variable 1 antibody
EP22706805.3A EP4294529A1 (en) 2021-02-17 2022-02-17 Multispecific anti-tcr delta variable 1 antibodies
ARP220100334A AR124909A1 (en) 2021-02-17 2022-02-17 ANTI-VARIABLE d 1 TCR ANTIBODIES
ARP220100335A AR124910A1 (en) 2021-02-17 2022-02-17 MULTI-SPECIFIC TCR ANTI-VARIABLE d 1 ANTIBODIES
MX2023009360A MX2023009360A (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies.
EP22705063.0A EP4294527A1 (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
IL305024A IL305024A (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
JP2023573494A JP2024509332A (en) 2021-02-17 2022-02-17 Multispecific anti-TCRδ variable region 1 antibody
CA3207265A CA3207265A1 (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
AU2022224391A AU2022224391A1 (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
JP2023548885A JP2024506682A (en) 2021-02-17 2022-02-17 Anti-TCR δ chain variable region 1 antibody
BR112023016587A BR112023016587A2 (en) 2021-02-17 2022-02-17 MULTI-SPECIFIC ANTI-TCR ANTIBODIES OF DELTA 1 VARIABLE
PCT/EP2022/054011 WO2022175414A1 (en) 2021-02-17 2022-02-17 Multispecific anti-tcr delta variable 1 antibodies
KR1020237031271A KR20230160253A (en) 2021-02-17 2022-02-17 anti-TCR delta variable 1 antibody
TW111105807A TW202246338A (en) 2021-02-17 2022-02-17 Anti-tcr delta variable 1 antibodies
AU2022222299A AU2022222299A1 (en) 2021-02-17 2022-02-17 Multispecific anti-tcr delta variable 1 antibodies
TW111105808A TW202302639A (en) 2021-02-17 2022-02-17 Multispecific anti-tcr delta variable 1 antibodies
CONC2023/0003009A CO2023003009A2 (en) 2020-08-14 2023-03-13 Multispecific anti-tcr delta variable 1 antibodies
US18/451,047 US20240132599A1 (en) 2021-02-17 2023-08-16 Multispecific anti-tcr delta variable 1 antibodies
CL2023002435A CL2023002435A1 (en) 2021-02-17 2023-08-17 Multispecific anti-TCR delta 1 variable antibodies
CONC2023/0011853A CO2023011853A2 (en) 2021-02-17 2023-09-07 Anti-tcr delta variable 1 antibodies
CONC2023/0011973A CO2023011973A2 (en) 2021-02-17 2023-09-08 Multispecific anti-TCR delta 1 variable antibodies
ECSENADI202370428A ECSP23070428A (en) 2021-02-17 2023-09-15 MULTI-SPECIFIC TCR ANTI-VARIABLE DELTA 1 ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2102224.9A GB202102224D0 (en) 2021-02-17 2021-02-17 Anti-TRC delta variable 1 antibodies

Publications (1)

Publication Number Publication Date
GB202102224D0 true GB202102224D0 (en) 2021-03-31

Family

ID=75338841

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2102224.9A Ceased GB202102224D0 (en) 2020-08-14 2021-02-17 Anti-TRC delta variable 1 antibodies

Country Status (2)

Country Link
AR (2) AR124909A1 (en)
GB (1) GB202102224D0 (en)

Also Published As

Publication number Publication date
AR124909A1 (en) 2023-05-17
AR124910A1 (en) 2023-05-17

Similar Documents

Publication Publication Date Title
LT3872091T (en) Antibodies against sars-cov-2
IL290537A (en) Therapeutic uses of anti-tcr delta variable 1 antibodies
IL285626A (en) Claudin 6 antibodies and uses thereof
IL285746A (en) High-affinity anti-mertk antibodies and uses thereof
SI4010082T1 (en) Multispecific anti-tcr delta variable 1 antibodies
IL308741A (en) Anti-sirp-alpha antibodies
IL307170A (en) Anti-tau antibodies and uses thereof
GB202102224D0 (en) Anti-TRC delta variable 1 antibodies
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202105110D0 (en) Anti-CD73 antibodies
GB202111685D0 (en) Anti-tcr delta variable 1 antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB202102222D0 (en) Multispecific anti-TCR delta variable 1 antibodies
IL308382A (en) Novel anti-cd276 antibodies and the uses thereof
IL310245A (en) Anti-hla-g antibodies
GB202208773D0 (en) Anti-SARS2-S antibodies
IL308782A (en) Antibodies
IL308100A (en) Antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
IL299767A (en) Anti-αlpha-4-βeta-7 antibodies
GB202104128D0 (en) Antibodies
GB202103388D0 (en) Antibodies
GB202102401D0 (en) Antibodies
GB202102227D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)